These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22099257)

  • 21. Identification of small molecules with type I interferon inducing properties by high-throughput screening.
    Martínez-Gil L; Ayllon J; Ortigoza MB; García-Sastre A; Shaw ML; Palese P
    PLoS One; 2012; 7(11):e49049. PubMed ID: 23145065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of influenza A nucleoprotein as an antiviral target.
    Kao RY; Yang D; Lau LS; Tsui WH; Hu L; Dai J; Chan MP; Chan CM; Wang P; Zheng BJ; Sun J; Huang JD; Madar J; Chen G; Chen H; Guan Y; Yuen KY
    Nat Biotechnol; 2010 Jun; 28(6):600-5. PubMed ID: 20512121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of covalent active site inhibitors of dengue virus protease.
    Koh-Stenta X; Joy J; Wang SF; Kwek PZ; Wee JL; Wan KF; Gayen S; Chen AS; Kang C; Lee MA; Poulsen A; Vasudevan SG; Hill J; Nacro K
    Drug Des Devel Ther; 2015; 9():6389-99. PubMed ID: 26677315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance.
    Zhang J; Hu Y; Foley C; Wang Y; Musharrafieh R; Xu S; Zhang Y; Ma C; Hulme C; Wang J
    Sci Rep; 2018 Mar; 8(1):4653. PubMed ID: 29545578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity.
    Shih SR; Chu TY; Reddy GR; Tseng SN; Chen HL; Tang WF; Wu MS; Yeh JY; Chao YS; Hsu JT; Hsieh HP; Horng JT
    J Biomed Sci; 2010 Feb; 17(1):13. PubMed ID: 20178582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of small molecular polyphenols as entry inhibitors against H(5)N(1).
    Yang J; Yang JX; Zhang F; Chen G; Pan W; Yu R; Wu S; Tien P
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2680-4. PubMed ID: 24803363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.
    Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30545063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel cell-based hepatitis C virus infection assay for quantitative high-throughput screening of anti-hepatitis C virus compounds.
    Hu Z; Lan KH; He S; Swaroop M; Hu X; Southall N; Zheng W; Liang TJ
    Antimicrob Agents Chemother; 2014; 58(2):995-1004. PubMed ID: 24277038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitors.
    Canales E; Carlson JS; Appleby T; Fenaux M; Lee J; Tian Y; Tirunagari N; Wong M; Watkins WJ
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4288-92. PubMed ID: 22664130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.
    Zeng J; Weissmann F; Bertolin AP; Posse V; Canal B; Ulferts R; Wu M; Harvey R; Hussain S; Milligan JC; Roustan C; Borg A; McCoy L; Drury LS; Kjaer S; McCauley J; Howell M; Beale R; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2405-2423. PubMed ID: 34198322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel influenza virus NS1 antagonists block replication and restore innate immune function.
    Basu D; Walkiewicz MP; Frieman M; Baric RS; Auble DT; Engel DA
    J Virol; 2009 Feb; 83(4):1881-91. PubMed ID: 19052087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection.
    Wang BX; Wei L; Kotra LP; Brown EG; Fish EN
    Viruses; 2017 May; 9(5):. PubMed ID: 28498306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction.
    D'Agostino I; Giacchello I; Nannetti G; Fallacara AL; Deodato D; Musumeci F; Grossi G; Palù G; Cau Y; Trist IM; Loregian A; Schenone S; Botta M
    Eur J Med Chem; 2018 Sep; 157():743-758. PubMed ID: 30142611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of novel influenza inhibitors targeting the interaction of dsRNA with the NS1 protein by structure-based virtual screening.
    Ai H; Zheng F; Zhu C; Sun T; Zhang L; Liu X; Li X; Zhu G; Liu H
    Int J Bioinform Res Appl; 2010; 6(5):449-60. PubMed ID: 21224203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based library design in efficient discovery of novel inhibitors.
    Yan S; Selliah R
    Methods Mol Biol; 2011; 685():175-90. PubMed ID: 20981524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy.
    Marsili G; Acchioni C; Remoli AL; Amatore D; Sgarbanti R; De Angelis M; Orsatti R; Acchioni M; Astolfi A; Iraci N; Puzelli S; Facchini M; Perrotti E; Cecchetti V; Sabatini S; Superti F; Agamennone M; Barreca ML; Hiscott J; Nencioni L; Sgarbanti M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
    Shiryaev VA; Radchenko EV; Palyulin VA; Zefirov NS; Bormotov NI; Serova OA; Shishkina LN; Baimuratov MR; Bormasheva KM; Gruzd YA; Ivleva EA; Leonova MV; Lukashenko AV; Osipov DV; Osyanin VA; Reznikov AN; Shadrikova VA; Sibiryakova AE; Tkachenko IM; Klimochkin YN
    Eur J Med Chem; 2018 Oct; 158():214-235. PubMed ID: 30218908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
    Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.
    Muratore G; Goracci L; Mercorelli B; Foeglein Á; Digard P; Cruciani G; Palù G; Loregian A
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6247-52. PubMed ID: 22474359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification, synthesis and pharmacological evaluation of novel anti-EV71 agents via cyclophilin A inhibition.
    Yan W; Qing J; Mei H; Nong J; Huang J; Zhu J; Jiang H; Liu L; Zhang L; Li J
    Bioorg Med Chem Lett; 2015 Dec; 25(24):5682-6. PubMed ID: 26564266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.